Cargando…
The Effect of Montelukast on Liver Damage in an Experimental Obstructive Jaundice Model
BACKGROUND: Montelukast is a cysteinyl-leukotriene type 1 (CysLT(1)) selective receptor antagonist. In recent years, investigations have shown that montelukast possesses secondary anti-inflammatory activities and also antioxidant effects. For this reason, we aimed to determine the possible effects o...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger Verlag für Medizin und Naturwissenschaften GmbH
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789965/ https://www.ncbi.nlm.nih.gov/pubmed/26989383 http://dx.doi.org/10.1159/000375434 |